ATO-101 (211At-labeled girentuximab) - ATONCO
Rencarex (girentuximab) - Heidelberg Pharma, Esteve, Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT07260162
 
Dec 4, 2025
 
Next